GammaDelta Therapeutics has been founded on pioneering research into gamma delta (??) T cells led by Professor Adrian Hayday and Dr Oliver Nussbaumer at King’s College London and the Francis Crick Institute and funded in part by Cancer Research UK. The Company has a team of experienced management, strong academic pedigree and excellent potential for clinical development.